# Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy

> **NCT06419140** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Zhejiang Cancer Hospital** · enrollment: 138 (estimated)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Standard SOX/XELOX adjuvant chemotherapy plus multimodal rehabilitation

## Key facts

- **NCT ID:** NCT06419140
- **Lead sponsor:** Zhejiang Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-06-01
- **Primary completion:** 2025-05-01
- **Final completion:** 2025-12-31
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2024-05-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06419140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06419140, "Multimodal Rehabilitation on Gastric Adenocarcinoma Patients Following Radical D2 Gastrectomy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06419140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*